Ansam Alani

Ansam Alani is a seasoned pharmacovigilance global expert physician currently at Pierre Fabre Group since July 2022, following a role as a pharmacovigilance physician at Recordati Rare Diseases. With extensive experience in global pharmacovigilance activities, Ansam has effectively managed individual case safety reports, ensured compliance with regulations, and drafted numerous periodic reports throughout various roles, including serving as a leader for a pharmacovigilance team at Servier Pharmaceuticals. Previous positions include a safety officer doctor at Hopital Foch and general practitioner in private practice, alongside educational qualifications in pharmacovigilance and drug safety from Université Paris Cité and MedDRA coding.